Year |
Citation |
Score |
2020 |
Brunner HI, Quartier P, Alexeeva E, Constantin T, Koné-Paut I, Marzan K, Schneider R, Wulffraat NM, Chasnyk V, Tirosh I, Kallinich T, Kuemmerle-Deschner J, Wouters C, Lauwerys B, Nikishina I, et al. Efficacy and Safety of Canakinumab in sJIA Patients with and without Fever at Baseline: Results from an Open-label, Active Treatment Extension Study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32648697 DOI: 10.1002/Art.41436 |
0.333 |
|
2019 |
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, et al. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatric Rheumatology Online Journal. 17: 66. PMID 31575380 DOI: 10.1186/S12969-019-0345-2 |
0.317 |
|
2019 |
Mallalieu NL, Wimalasundera S, Hsu JC, Douglass W, Wells C, Penades IC, Cuttica R, Huppertz HI, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial. Pediatric Rheumatology Online Journal. 17: 57. PMID 31438986 DOI: 10.1186/S12969-019-0364-Z |
0.345 |
|
2019 |
Foeldvari I, Constantin T, Vojinović J, Horneff G, Chasnyk V, Dehoorne J, Panaviene V, Sušić G, Stanevicha V, Kobusinska K, Zuber Z, Dobrzyniecka B, Nikishina I, Bader-Meunier B, Breda L, et al. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial. Arthritis Research & Therapy. 21: 125. PMID 31122296 DOI: 10.1186/S13075-019-1916-9 |
0.384 |
|
2019 |
Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, et al. Consensus-based recommendations for the management of juvenile localised scleroderma. Annals of the Rheumatic Diseases. PMID 30826775 DOI: 10.1136/Annrheumdis-2018-214697 |
0.358 |
|
2019 |
Foeldvari I, Torok K, Ambartsumyan L, Anton J, Beyer C, Blakley M, Constantin T, Reis PC, Curran M, Cutolo M, Galdo FD, Denton C, Fligelstone K, Hinrichs B, Höger A, et al. Ab0966 Proposal Of Outcome Measures To Be Used On A 12-Month Open Label Drug Trial In Juvenile Systemic Sclerosis. Results Of The 3Rd Consensus Meeting In Hamburg December 2018 Annals of the Rheumatic Diseases. 78: 1949-1949. DOI: 10.1136/Annrheumdis-2019-Eular.3198 |
0.329 |
|
2019 |
Krol R, Swart JF, Giancane G, Roock SD, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok FR, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, Oliveira SKDE, et al. Op0058 Development Of Inflammatory Bowel Disease During Treatment With Etanercept In Patientswith Juvenile Idiopathic Arthritis Annals of the Rheumatic Diseases. 78: 100-101. DOI: 10.1136/Annrheumdis-2019-Eular.3189 |
0.377 |
|
2018 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat NM, Horneff G, Kasapcopur O, Schneider R, Anton J, Barash J, Berner R, Corona F, Cuttica R, Fouillet-Desjonqueres M, Fischbach M, et al. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Annals of the Rheumatic Diseases. PMID 30269054 DOI: 10.1136/Annrheumdis-2018-213150 |
0.338 |
|
2018 |
Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N. The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatology International. 38: 243-250. PMID 29637341 DOI: 10.1007/S00296-018-3955-Y |
0.35 |
|
2018 |
Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, Gepstein R, Heiligenhaus A, Pilkington CA, Simonini G, Uziel Y, Vastert SJ, Wulffraat NM, Haasnoot AM, Walscheid K, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Annals of the Rheumatic Diseases. PMID 29592918 DOI: 10.1136/Annrheumdis-2018-213131 |
0.354 |
|
2018 |
Wimalasundera S, Penades IC, Cuttica R, Huppertz H-, Joos R, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Douglass W, Wells C, Kimura Y, Wouters C. THU0598 Safety of tocilizumab in patients aged <2 years with active systemic juvenile idiopathic arthritis treated for one year Annals of the Rheumatic Diseases. 77: 499-499. DOI: 10.1136/Annrheumdis-2018-Eular.2628 |
0.318 |
|
2017 |
Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, ... ... Constantin T, et al. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Annals of the Rheumatic Diseases. 76: 782-791. PMID 28385804 DOI: 10.1136/Annrheumdis-2017-211401 |
0.31 |
|
2017 |
Mallalieu N, Hsu J, Wang K, Wimalasundera S, Wells C, Penades IC, Cuttica R, Huppertz H, Joos R, Kimura Y, Milojevic D, Rosenkranz M, Schikler K, Constantin T, Wouters C. OP0197 Evaluation of a dosing regimen for tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.2386 |
0.315 |
|
2016 |
Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Annals of the Rheumatic Diseases. PMID 27515057 DOI: 10.1136/Annrheumdis-2016-209247 |
0.333 |
|
2016 |
Constantin T, Foeldvari I, Vojinovic J, Horneff G, Burgos-Vargas R, Nikishina I, Akikusa JD, Avcin T, Chaitow J, Koskova E, Lauwerys BR, Calvo Penades I, Flato B, Gamir ML, Huppertz HI, et al. Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis. The Journal of Rheumatology. 43: 816-24. PMID 26932344 DOI: 10.3899/Jrheum.150430 |
0.356 |
|
2016 |
Odler B, Cseh Á, Constantin T, Fekete G, Losonczy G, Tamási L, Benke K, Szilveszter B, Müller V. Long time enzyme replacement therapy stabilizes obstructive lung disease and alters peripheral immune cell subsets in Fabry patients. The Clinical Respiratory Journal. PMID 26763180 DOI: 10.1111/Crj.12446 |
0.3 |
|
2016 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Alexeeva E, Schneider R, Kone-Paut I, Schikler K, Marzan K, Wulffraat N, Padeh S, Chasnyk V, Wouters C, Kuemmerle-Deschner JB, Kallinich T, et al. THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial Annals of the Rheumatic Diseases. 75: 265-266. DOI: 10.1136/Annrheumdis-2016-Eular.3835 |
0.373 |
|
2016 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Kuemmerle-Deschner JB, Kallinich T, Lauwerys B, et al. THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial Annals of the Rheumatic Diseases. 75: 401-402. DOI: 10.1136/Annrheumdis-2016-Eular.2658 |
0.336 |
|
2015 |
Horneff G, Ruperto N, Brunner H, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Deschner JK, Kallinich T, et al. Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever Pediatric Rheumatology. 13. DOI: 10.1186/1546-0096-13-S1-O83 |
0.348 |
|
2015 |
Foeldvari I, Györgyi Z, Baildam E, Batu ED, Blakley M, Cakan M, Curran M, Fligelstone K, Mouthon L, Nemcova D, Pilkington C, Ruperto N, Tsinti M, Tsitsami E, Urbanvica K, ... Constantin T, et al. AB0984 Development of a Juvenile Systemic Sclerosis Response Index (JSSRI): Table 1 Annals of the Rheumatic Diseases. 74: 1227-1228. DOI: 10.1136/Annrheumdis-2015-Eular.5924 |
0.302 |
|
2015 |
Swart J, Pistorio A, Bovis F, Alekseeva E, Hofer M, Nielsen S, Anton J, Consolaro A, Panaviene V, Stanevicha V, Trachana M, Ailioaie C, Quartier P, Benedetti FD, Tsitsami E, ... ... Constantin T, et al. OP0062 The Addition of One or More Biologics to Methotrexate in Children with Juvenile Idiopathic Arthritis Increases the Incidence of Infections and Serious Adverse Events. The 5882 Pharmachild Cohort Annals of the Rheumatic Diseases. 74: 91-91. DOI: 10.1136/Annrheumdis-2015-Eular.4397 |
0.352 |
|
2015 |
Ruperto N, Brunner H, Quartier P, Constantin T, Alexeeva E, Kone-Paut I, Marzan K, Wulffraat N, Schneider R, Padeh S, Chasnyk V, Wouters C, Deschner JK, Kallinich T, Lauwerys B, et al. FRI0496 Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis with and Without Fever Annals of the Rheumatic Diseases. 74: 608-608. DOI: 10.1136/Annrheumdis-2015-Eular.2050 |
0.364 |
|
2014 |
Moorthy LN, Roy E, Kurra V, Peterson MG, Hassett AL, Lehman TJ, Scott C, El-Ghoneimy D, Saad S, El Feky R, Al-Mayouf S, Dolezalova P, Malcova H, Herlin T, Nielsen S, ... ... Constantin T, et al. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatric Rheumatology Online Journal. 12: 49. PMID 25705138 DOI: 10.1186/1546-0096-12-49 |
0.349 |
|
2014 |
Enders FB, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman B, Lahdenne P, Magnusson B, Nistala K, Pilkington C, Ravelli A, Russo R, Brussel Mv, Net Jvd, Wedderburn L, et al. SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis Pediatric Rheumatology. 12: 89. DOI: 10.1186/1546-0096-12-S1-P89 |
0.339 |
|
2014 |
Pain C, Constantin T, Baildem E, Beyer C, Lenhartz H, Blackley M, Nemcova D, Pilkington C, Foeldvari I. Gastrointestinal involvement in juvenile systemic sclerosis: development of recommendations for screening and investigation Pediatric Rheumatology. 12: 52. DOI: 10.1186/1546-0096-12-S1-P52 |
0.334 |
|
2014 |
Consolaro A, Dolezalova P, Panaviene V, Christensen AE, Merino R, Constantin T, Martini A, Ravelli A. A multinational study of the epidemiology, treatment and outcome of childhood arthritis (epoca study): preliminary data from 6,940 patients Pediatric Rheumatology. 12: 1-2. DOI: 10.1186/1546-0096-12-S1-O8 |
0.34 |
|
2013 |
Constantin T, Pain C, Toplak N, Moll M, Konert I, Piotto D, Ayaz N, Nemkova D, Hoeger P, Cutolo M, Smith V, Foeldvari I. PReS-FINAL-2126: How to follow up children with Raynaud syndrome - recommendations based on the Hamburg consensus meeting 2012 Pediatric Rheumatology. 11: 138. DOI: 10.1186/1546-0096-11-S2-P138 |
0.353 |
|
2013 |
Ruperto N, Brunner H, Constantin T, Wulffraat N, Horneff G, Anton J, Berner R, Corona F, Cuttica R, Desjonqueres M, Fischbach M, Alessio M, Chieng A, Emminger W, Haddad E, et al. OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial Annals of the Rheumatic Diseases. 72: A97.3-A98. DOI: 10.1136/Annrheumdis-2013-Eular.341 |
0.337 |
|
2013 |
Constantin T, Pain C, Toplak N, Moll M, Iking-Konert C, Piotto D, Aktay N, Nemcova D, Hoeger P, Cutolo M, Smith V, Foeldvari I. SAT0484 Minimum Diagnostic Standards for Children with Raynaud’s Phenomenon - Results of the Consensus Meeting in Hamburg (Germany) on December 9, 2012 Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2208 |
0.409 |
|
2013 |
Quartier P, Erguven M, Horneff G, Berkun Y, Lheritier K, Kim D, Abrams K, Constantin T. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study Annals of the Rheumatic Diseases. 71: 705-705. DOI: 10.1136/Annrheumdis-2012-Eular.1184 |
0.342 |
|
2013 |
Ruperto N, Brunner H, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, et al. AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis Annals of the Rheumatic Diseases. 71: 705-705. DOI: 10.1136/Annrheumdis-2012-Eular.1180 |
0.319 |
|
2012 |
Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. The New England Journal of Medicine. 367: 2396-406. PMID 23252526 DOI: 10.1056/Nejmoa1205099 |
0.35 |
|
2011 |
Garan D, Bence Z, Gács Z, Szabó A, Constantin T. ANCA-associated vasculitides in childhood Pediatric Rheumatology. 9: 95. DOI: 10.1186/1546-0096-9-S1-P95 |
0.33 |
|
2011 |
Ruperto N, Brunner H, Horneff G, Quartier P, Constantin T, Berkun Y, Erguven M, Kallinich T, Brik R, Wulffraat N, Ferrandiz M, Rutkowska-Sak L, Ozdogan H, McCann L, Lheritier K, et al. Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study Pediatric Rheumatology. 9: 1-2. DOI: 10.1186/1546-0096-9-S1-O21 |
0.316 |
|
2010 |
Toplak N, Dolezalovà P, Constantin T, Sedivà A, Paši? S, Cižnar P, Wolska-Ku?nierz B, Harja?ek M, Stefan M, Ruperto N, Gattorno M, Av?in T. Periodic fever syndromes in Eastern and Central European countries: results of a pediatric multinational survey. Pediatric Rheumatology Online Journal. 8: 29. PMID 21539753 DOI: 10.1186/1546-0096-8-29 |
0.314 |
|
2010 |
Constantin T, Székely A, Ponyi A, Gulácsy V, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Medvecz M, Fiedler O, Széchey R, et al. Management of Fabry disease | Fabry-betegség - Terápiás útmutató Orvosi Hetilap. 151: 1243-1251. PMID 20656661 DOI: 10.1556/Oh.2010.28796 |
0.354 |
|
2010 |
Constantin T, Rákóczi E, Ponyi A, Ambrus C, Kádár K, Vastagh I, Dajnoki A, Tóth B, Bokrétás G, Müller V, Katona M, Csikós M, Fiedler O, Széchey R, Varga E, et al. Fabry disease diagnostic guideline | Fabry-betegség: Diagnosztikai útmutató Orvosi Hetilap. 151: 243-249. PMID 20133243 DOI: 10.1556/Oh.2010.28795 |
0.351 |
|
2009 |
Constantin T, Kálovics T, Ponyi A, Nagy E, Sallai K, Szabó L, Garami M, Müller J, Gergely P, Dankó K, Fekete G, Kálmánchey R. Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 15: CR164-9. PMID 19333200 |
0.521 |
|
2007 |
Constantin T, Ponyi A, Kálovics T, Orbán I, Molnár K, Dérfalvy B, Dicso F, Sallai A, Garami M, Balogh Z, Szalai Z, Fekete G, Dankó K. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis]. Orvosi Hetilap. 148: 1989-97. PMID 17932005 DOI: 10.1556/Oh.2007.27907 |
0.327 |
|
2007 |
Váncsa A, Ponyi A, Constantin T, Zeher M, Dankó K. Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatology International. 27: 435-9. PMID 17033833 DOI: 10.1007/S00296-006-0239-8 |
0.311 |
|
2006 |
Constantin T, Ponyi A, Orbán I, Molnár K, Dérfalvi B, Dicso F, Kálovics T, Müller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Dankó K. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity. 39: 223-32. PMID 16769656 DOI: 10.1080/08916930600622819 |
0.377 |
|
2005 |
Ponyi A, Constantin T, Garami M, András C, Tállai B, Váncsa A, Gergely L, Dankó K. Cancer-associated myositis: clinical features and prognostic signs. Annals of the New York Academy of Sciences. 1051: 64-71. PMID 16126945 DOI: 10.1196/Annals.1361.047 |
0.329 |
|
2005 |
Müller J, Garami M, Constantin T, Schmidt M, Fekete G, Kovács G. Meropenem in the treatment of febrile neutropenic children. Pediatric Hematology and Oncology. 22: 277-84. PMID 16020114 DOI: 10.1080/08880010590935167 |
0.308 |
|
2004 |
Ponyi A, Constantin T, Dankó K. Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap. Clinical Rheumatology. 23: 371-2. PMID 15293105 DOI: 10.1007/S10067-004-0903-X |
0.33 |
|
2004 |
Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine. 83: 35-42. PMID 14747766 DOI: 10.1097/01.Md.0000109755.65914.5E |
0.315 |
|
Low-probability matches (unlikely to be authored by this person) |
2017 |
Kuemmerle-Deschner JB, Hansmann S, Wulffraat NM, Vastert SJ, Hens K, Anton J, Avcin T, Martini A, Koné-Paut I, Uziel Y, Ravelli A, Wouters C, Shaw D, Özen S, Eikelberg A, ... ... Constantin T, et al. Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative. Annals of the Rheumatic Diseases. PMID 29021237 DOI: 10.1136/Annrheumdis-2017-211904 |
0.299 |
|
2018 |
Constantin T, Foeldvari I, Pain CE, Pálinkás A, Höger P, Moll M, Nemkova D, Weibel L, Laczkovszki M, Clements P, Torok KS. Development of minimum standards of care for juvenile localized scleroderma. European Journal of Pediatrics. PMID 29728839 DOI: 10.1007/S00431-018-3144-8 |
0.295 |
|
2017 |
Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, ... ... Constantin T, et al. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28382778 DOI: 10.1002/Art.40060 |
0.295 |
|
2016 |
Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Annals of the Rheumatic Diseases. PMID 27802961 DOI: 10.1136/Annrheumdis-2016-210112 |
0.294 |
|
2014 |
Horneff G, Burgos-Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyk VG, Dehoorne J, Panaviene V, Susic G, Stanevica V, Kobusinska K, Zuber Z, Mouy R, Rumba-Rozenfelde I, Breda L, et al. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Annals of the Rheumatic Diseases. 73: 1114-22. PMID 23696632 DOI: 10.1136/Annrheumdis-2012-203046 |
0.292 |
|
2013 |
Quartier P, Brunner H, Constantin T, Padeh S, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira S, Uziel Y, Viola S, Nistala K, Wouters C, Lheritier K, et al. PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis Pediatric Rheumatology. 11: 169. DOI: 10.1186/1546-0096-11-S2-P169 |
0.289 |
|
2006 |
Constantin T, Ponyi A, Varga E, Dankó K, Fekete G, Kovács G. Antiphospholipid syndrome accompanied by a silent splenic infarct in a patient with juvenile SLE. Rheumatology International. 26: 951-2. PMID 16625341 DOI: 10.1007/S00296-006-0125-4 |
0.288 |
|
2018 |
De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, ... ... Constantin T, et al. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. The New England Journal of Medicine. 378: 1908-1919. PMID 29768139 DOI: 10.1056/Nejmoa1706314 |
0.274 |
|
2007 |
lmánchey RK, Constantin T, Kálovics T, Sallai K, Nagy E, Gergely P, Fekete G, Ponyi A. IAP025 Prevalence of antiphospholipid and antinuclear antibodies in children with epilepsy European Journal of Paediatric Neurology. 11: 93. DOI: 10.1016/S1090-3798(08)70609-3 |
0.273 |
|
2004 |
Constantin T, Ponyi A, Fekete G. Clinical relevance of anti-phospholipid antibody tests in childhood. European Journal of Pediatrics. 163: 507. PMID 15168112 DOI: 10.1007/S00431-004-1478-X |
0.27 |
|
2010 |
Szodoray P, Alex P, Knowlton N, Centola M, Dozmorov I, Csipo I, Nagy AT, Constantin T, Ponyi A, Nakken B, Danko K. Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand. Rheumatology (Oxford, England). 49: 1867-77. PMID 20591831 DOI: 10.1093/Rheumatology/Keq151 |
0.267 |
|
2017 |
McCann LJ, Pilkington CA, Huber AM, Ravelli A, Appelbe D, Kirkham JJ, Williamson PR, Aggarwal A, Christopher-Stine L, Constantin T, Feldman BM, Lundberg I, Maillard S, Mathiesen P, Murphy R, et al. Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. Annals of the Rheumatic Diseases. PMID 29084729 DOI: 10.1136/Annrheumdis-2017-212141 |
0.264 |
|
2014 |
Constantin T, Zoltan G, Foeldvari I, Weiser P, Szabo A. Recent Advances in Systemic Scleroderma in Childhood Annals of Paediatric Rheumatology. 3: 146-157. DOI: 10.5455/Apr.120420141451 |
0.262 |
|
2005 |
Ponyi A, Borgulya G, Constantin T, Váncsa A, Gergely L, Dankó K. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford, England). 44: 83-8. PMID 15381789 DOI: 10.1093/Rheumatology/Keh404 |
0.258 |
|
2017 |
Foeldvari I, Furst DF, Anton J, Baildem E, Blakley M, Constantin T, Reis PC, Curran M, Cutolo M, Denton C, Fligelstone K, Hinrichs B, Ingegnoli F, Kienast A, Němcova D, et al. AB0958 Proposal for a juvenile systemic sclerosis response index (JSSCRI): result of the consensus meeting in hamburg. germany 11th of december 2016 Annals of the Rheumatic Diseases. 76: 1390-1390. DOI: 10.1136/Annrheumdis-2017-Eular.2862 |
0.257 |
|
2023 |
Foeldvari I, Torok KS, Antón J, Blakley M, Constantin T, Cutolo M, Denton CP, Fligelstone K, Hinrichs B, Li SC, Maillard S, Marrani E, Moinzadeh P, Orteu CH, Pain CE, et al. Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022. Expert Review of Clinical Immunology. PMID 38149621 DOI: 10.1080/1744666X.2023.2298354 |
0.256 |
|
2008 |
Erdos M, Németh K, Tóth B, Constantin T, Rákóczi E, Ponyi A, Dajnoki A, Grubits J, Pintér I, Garzuly F, Hahn K, Bencsik K, Vécsei L, Fekete G, Maródi L. Novel sequence variants of the alpha-galactosidase A gene in patients with Fabry disease. Molecular Genetics and Metabolism. 95: 224-8. PMID 18849176 DOI: 10.1016/J.Ymgme.2008.09.002 |
0.255 |
|
2018 |
Foster HE, Vojinovic J, Constantin T, Martini A, Dolezalova P, Uziel Y, Smith EMD, Lamot L, Wouters C, Avcin T, Wulffraat N. Educational initiatives and training for paediatric rheumatology in Europe. Pediatric Rheumatology Online Journal. 16: 77. PMID 30526605 DOI: 10.1186/S12969-018-0289-Y |
0.254 |
|
2022 |
Szekanecz Z, Balog A, Constantin T, Czirják L, Géher P, Kovács L, Kumánovics G, Nagy G, Rákóczi É, Szamosi S, Szűcs G, Vályi-Nagy I. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients. Expert Reviews in Molecular Medicine. 24: e13. PMID 35311631 DOI: 10.1017/erm.2022.10 |
0.252 |
|
2020 |
Foeldvari I, Culpo R, Sperotto F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington C, Toplak N, van Royen A, Saad Magalhaes C, et al. Consensus-based recommendations for the management of juvenile systemic sclerosis. Rheumatology (Oxford, England). PMID 33147624 DOI: 10.1093/rheumatology/keaa584 |
0.245 |
|
2019 |
Dolezalova P, Anton J, Avcin T, Beresford MW, Brogan PA, Constantin T, Egert Y, Foeldvari I, Foster HE, Hentgen V, Kone-Paut I, Kuemmerle-Deschner JB, Lahdenne P, Magnusson B, Martini A, et al. The European network for care of children with paediatric rheumatic diseases: care across borders. Rheumatology (Oxford, England). PMID 30668879 DOI: 10.1093/Rheumatology/Key439 |
0.244 |
|
2013 |
Debeljak M, Toplak N, Abazi N, Kolnik M, Szabados B, Mulaosmanovic V, Constantin T, Kuzmanovska D, Avcin T. AB0025 Prevalence of MEFV gene mutations in apparently healthy populations in balkan and central european countries Annals of the Rheumatic Diseases. 71: 638-639. DOI: 10.1136/Annrheumdis-2012-Eular.25 |
0.234 |
|
2013 |
Debeljak M, Toplak N, Abazi N, Kolnik M, Szabados B, Mulaosmanovic V, Radović J, Vojnović J, Constantin T, Kuzmanovska D, Avčin T. PW01-020 – MEFV mutations carrier rate in Central Europe Pediatric Rheumatology. 11: 1-1. DOI: 10.1186/1546-0096-11-S1-A73 |
0.225 |
|
2008 |
András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Dankó K. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. The Journal of Rheumatology. 35: 438-44. PMID 18203322 |
0.225 |
|
2021 |
Constantin T, Andrási N, Ponyi A, Goschler Á, Ablonczy L, Kincs J, Csóka M, Egyed B, Horváth Z, Kalocsai K, Káposzta R, Kardics K, Kemény V, Mosdósi B, Pék T, et al. Diagnosis and treatment of paediatric multisystem inflammatory syndrome Orvosi Hetilap. 162: 652-667. PMID 33838024 DOI: 10.1556/650.2021.32231 |
0.217 |
|
2022 |
Alongi A, Giancane G, Naddei R, Natoli V, Ridella F, Burrone M, Rosina S, Chedeville G, Alexeeva E, Horneff G, Foeldvari I, Filocamo G, Constantin T, Ruperto N, Ravelli A, et al. Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis. Rmd Open. 8. PMID 35256534 DOI: 10.1136/rmdopen-2021-002042 |
0.216 |
|
2017 |
Lomakina O, Alekseeva E, Valieva S, Bzarova T, Nikishina I, Zholobova E, Rodionovskaya S, Kaleda M, Nakagishi Y, Shimizu M, Mizuta M, Yachie A, Sugita Y, Okamoto N, Shabana K, ... ... Constantin T, et al. Proceedings of the 23 rd Paediatric Rheumatology European Society Congress: part three Pediatric Rheumatology. 15: 105-201. DOI: 10.1186/S12969-017-0141-9 |
0.212 |
|
2009 |
Dankó K, Ponyi A, Molnar AP, András C, Constantin T. Paraneoplastic myopathy. Current Opinion in Rheumatology. 21: 594-8. PMID 19730376 DOI: 10.1097/BOR.0b013e3283317fa5 |
0.211 |
|
2021 |
van Straalen JW, Krol RM, Giancane G, Panaviene V, Ailioaie LM, Doležalová P, Cattalini M, Susic G, Sztajnbok F, Maritsi D, Constantin T, Sawhney S, Rygg M, Oliveira SK, Nordal EB, et al. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology (Oxford, England). PMID 34508559 DOI: 10.1093/rheumatology/keab678 |
0.206 |
|
2008 |
Bognár M, Ponyi A, Hauser P, Müller J, Constantin T, Jakab Z, Schuler D, Garami M. Improper supplementation habits of folic acid intake by Hungarian pregnant women: improper recommendations. Journal of the American College of Nutrition. 27: 499-504. PMID 18978170 DOI: 10.1080/07315724.2008.10719731 |
0.198 |
|
2007 |
Müller J, Botyánszki A, Baki M, Schuler D, Karádi Z, Gács Z, Constantin T, Kemény V, Dobos M, Garami M. 1218 POSTER Do offsprings of fathers with testicular malignancies have disadvantages? European Journal of Cancer Supplements. 5: 166. DOI: 10.1016/S1359-6349(07)70699-7 |
0.193 |
|
2020 |
Hau L, Kállay K, Kertész G, Goda V, Kassa C, Horváth O, Liptai Z, Constantin T, Kriván G. Allogeneic haematopoietic stem cell transplantation in a refractory case of neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. 42: 102110. PMID 32408149 DOI: 10.1016/J.Msard.2020.102110 |
0.192 |
|
2023 |
Constantin T, Pék T, Horváth Z, Garan D, Szabó AJ. Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID. Inflammopharmacology. 31: 2221-2236. PMID 37460909 DOI: 10.1007/s10787-023-01272-3 |
0.19 |
|
2013 |
Foeldvari I, Constantin T, Höger P, Nemcova D, Pain C, Torok K, Weibel L, Clements P. AB1162 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part I. diagnosis and assessment of the disease Annals of the Rheumatic Diseases. 71: 704.3-704. DOI: 10.1136/ANNRHEUMDIS-2012-EULAR.1160 |
0.186 |
|
2016 |
Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP, Aktay Ayaz N, Nemcova D, Hoeger PH, Cutolo M, Smith V, Foeldvari I. Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring. Clinical and Experimental Rheumatology. PMID 27494080 |
0.167 |
|
2020 |
Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz HI, Lovell DJ, Wolfs T, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok F, Maritsi D, Constantin T, et al. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Research & Therapy. 22: 71. PMID 32264969 DOI: 10.1186/s13075-020-02167-2 |
0.166 |
|
2020 |
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, et al. Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC). Pediatric Rheumatology Online Journal. 18: 14. PMID 32046749 DOI: 10.1186/s12969-019-0396-4 |
0.16 |
|
2014 |
Culpo R, Vastert SJ, Ravelli A, Wulffraat N, Foeldvari I, Zulian F, Anton J, Avcin T, Baildam E, Boros C, Chaitow J, Constantin T, Dolezalova P, Kasapcopur O, de Oliveira SK, et al. SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis Pediatric Rheumatology. 12. DOI: 10.1186/1546-0096-12-S1-P117 |
0.159 |
|
2021 |
Szekanecz Z, Bogos K, Constantin T, Fülesdi B, Müller V, Rákóczi É, Várkonyi I, Vályi-Nagy I. Antiviral and anti-inflammatory therapies in COVID-19 Orvosi Hetilap. 162: 643-651. PMID 33838023 DOI: 10.1556/650.2021.32230 |
0.159 |
|
2024 |
Foeldvari I, Bohn M, Petrushkin H, Angeles Han S, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer JH, Díaz-Cascajosa J, Edelsten C, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, et al. A practical approach to uveitis screening in children with juvenile idiopathic arthritis. The British Journal of Ophthalmology. PMID 38575198 DOI: 10.1136/bjo-2023-324406 |
0.157 |
|
2022 |
van Dijkhuizen EHP, Ridella F, Naddei R, Trincianti C, Avrusin I, Mazzoni M, Sutera D, Ayaz NA, Penades IC, Constantin T, Herlin T, Oliveira SK, Rygg M, Sanner H, Susic G, et al. Validity and reliability of four parent/patient reported outcome measures for juvenile idiopathic arthritis remote monitoring. Arthritis Care & Research. PMID 35015379 DOI: 10.1002/acr.24855 |
0.148 |
|
2013 |
Foeldvari I, Constantin T, Hoeger P, Moll M, Nemcova D, Pain C, Torok K, Weibel L, Clements P. FRI0409 Do we need minimum standards in care for children with localized scleroderma?- result of the consensus meeting in hamburg germany on the 11th of december 2011. part ii. treatment of juvenile localised scleroderma Annals of the Rheumatic Diseases. 72: A512.1-A512. DOI: 10.1136/annrheumdis-2013-eular.1536 |
0.143 |
|
2013 |
Foeldvari I, Constantin T, Höger P, Nemcova D, Pain C, Torok K, Weibel L, Clements P. AB1163 Looking for minimum standards in care for children with localized scleroderma-result of the consensus meeting in hamburg germany on the 11th of december 2011. Part II. treatment of juvenile localised scleroderma Annals of the Rheumatic Diseases. 71: 704.4-704. DOI: 10.1136/ANNRHEUMDIS-2012-EULAR.1161 |
0.141 |
|
2024 |
Dobner S, Kulcsár A, Liptai Z, Vojnisek Z, Constantin T, Szabó L. Vaccination proposal for patients on onasemnogene abeparvovec therapy. European Journal of Paediatric Neurology : Ejpn : Official Journal of the European Paediatric Neurology Society. 49: 95-99. PMID 38457958 DOI: 10.1016/j.ejpn.2024.02.010 |
0.14 |
|
2011 |
Vastagh I, Constantin T, Kéri A, Rudas G, Fekete G, Bereczki D. [Neurological complications of Fabry-disease]. IdeggyóGyáSzati Szemle. 64: 29-35. PMID 21428036 |
0.132 |
|
2021 |
Jeyaratnam J, Simon A, Calvo I, Constantin T, Shcherbina A, Hofer M, Gattorno M, Martini A, Bader-Meunier B, Vastert B, Levy J, Dekker E, de Benedetti F, Frenkel J. Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial. Rheumatology (Oxford, England). PMID 34554243 DOI: 10.1093/rheumatology/keab696 |
0.132 |
|
2006 |
Gadó J, Schlick B, Bárány O, Németh J, Müller J, Csóka M, Constantin T, Vonnák E, Böcskei R, Hauser P, Kovács G. [The function of the immune system after the treatment of pediatric malignant diseases]. Orvosi Hetilap. 147: 1731-8. PMID 17087017 |
0.131 |
|
2003 |
Constantin T, Ponyi A, Garami M, Gergely L, Fekete G, Dankó K. [Clinical characteristics of juvenile dermatomyositis]. Orvosi Hetilap. 144: 1245-50. PMID 12901181 |
0.122 |
|
2022 |
Constantin T, Kulcsár A, Krivácsy P, Mészner Z, Ponyi A, Tóth A, Ónozó B, Szekanecz Z. SARS-CoV-2 infection and its prevention in pediatric autoimmune diseases Orvosi Hetilap. 163: 414-423. PMID 35279647 DOI: 10.1556/650.2022.32448 |
0.12 |
|
2002 |
András C, Ponyi A, Constantin T, Csiki Z, Illés A, Szegedi G, Dankó K. [Myositis associated with tumors]. Magyar Onkologia. 46: 253-9. PMID 12368921 |
0.111 |
|
2015 |
Debeljak M, Toplak N, Abazi N, Szabados B, Mulaosmanović V, Radović J, Perko D, Vojnović J, Constantin T, Kuzmanovska D, Avčin T. The carrier rate and spectrum of MEFV gene mutations in central and southeastern European populations. Clinical and Experimental Rheumatology. 33: S19-23. PMID 26399837 |
0.092 |
|
2017 |
Benedetti FD, Anton J, Gattorno M, Lachmann H, Kone-Paut I, Ozen S, Frenkel J, Simon A, Zeft A, Ben-Chetrit E, Hoffman HM, Joubert Y, Lheritier K, Speziale A, Guido J, ... ... Constantin T, et al. Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016. Pediatric Rheumatology. 15. DOI: 10.1186/S12969-017-0142-8 |
0.081 |
|
2007 |
Dabasi G, Hauser P, Kertész GP, Balázs G, Karádi Z, Constantin T, Bognár L, Klekner A, Schuler D, Garami M. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide]. Magyar Onkologia. 51: 229-34. PMID 17922063 |
0.066 |
|
2006 |
Bognár M, Hauser P, Jakab Z, Müller J, Constantin T, Schuler D, Garami M. [Folic acid supplementation for pregnant women in Hungary]. Orvosi Hetilap. 147: 1633-8. PMID 17017678 |
0.047 |
|
Hide low-probability matches. |